# TOFACITINIB CITRATE

NDC: 85972-121
Generic name: TOFACITINIB CITRATE
Labeler / Manufacturer: Stellon Biotech Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20261001

FDA application: ANDA218821

## Active ingredients

- TOFACITINIB CITRATE: 8.08 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"85972-121"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=85972-121